Published Date: 20 Dec 2024
Alarming mental health challenges among young cancer survivors, especially males, demand action
Read Full NewsAn investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.
A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.
The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.
Both drugs increase overall and progression-free survival.
1.
Inadvertent lung cancer screening results are discussed in a new study.
2.
Global inequalities found in cancer research funding
3.
Tumor characteristics found to differ for melanomas in children, teens and young adults
4.
Routine breast cancer screening can bring better outcomes for patients
5.
What Comes After Cancer?
1.
Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data
2.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
3.
Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation